170 related articles for article (PubMed ID: 21544813)
1. Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma.
Liang Y; Li WW; Yang BW; Tao ZH; Sun HC; Wang L; Xia JL; Qin LX; Tang ZY; Fan J; Wu WZ
Int J Cancer; 2012 Apr; 130(8):1745-54. PubMed ID: 21544813
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of ARNT2 promotes tumor growth and predicts poor prognosis in human hepatocellular carcinoma.
Li W; Liang Y; Yang B; Sun H; Wu W
J Gastroenterol Hepatol; 2015 Jun; 30(6):1085-93. PubMed ID: 25611915
[TBL] [Abstract][Full Text] [Related]
3. [Effects of ARNT2 gene on invasion and migration of human hepatocellular carcinoma HCCLM6 cell line].
Li WW; Wu WZ; Liang Y; Xiao CL; Tao ZH; Wang L; Sun HC; Fan J
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):27-31. PubMed ID: 20128965
[TBL] [Abstract][Full Text] [Related]
4. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
[TBL] [Abstract][Full Text] [Related]
5. Homeobox B9 is overexpressed in hepatocellular carcinomas and promotes tumor cell proliferation both in vitro and in vivo.
Li F; Dong L; Xing R; Wang L; Luan F; Yao C; Ji X; Bai L
Biochem Biophys Res Commun; 2014 Feb; 444(2):241-7. PubMed ID: 24462859
[TBL] [Abstract][Full Text] [Related]
6. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
7. 4S polycyclic aromatic hydrocarbon receptor (glycine N-methyltransferase) and the aryl hydrocarbon receptor nuclear translocator (hypoxia inducible factor-1β) interaction in Chinese hamster ovary and rat hepatoma cells: 4S PAH-R/ARNT hetero-oligomers?
Sterling KM
J Cell Biochem; 2011 Aug; 112(8):2015-8. PubMed ID: 21445860
[TBL] [Abstract][Full Text] [Related]
8. Tiam1 is associated with hepatocellular carcinoma metastasis.
Huang J; Ye X; Guan J; Chen B; Li Q; Zheng X; Liu L; Wang S; Ding Y; Ding Y; Chen L
Int J Cancer; 2013 Jan; 132(1):90-100. PubMed ID: 22573407
[TBL] [Abstract][Full Text] [Related]
9. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
10. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma.
Li A; Yan Q; Zhao X; Zhong J; Yang H; Feng Z; Du Y; Wang Y; Wang Z; Wang H; Zhou Y; Liu S; Nie Y
Oncotarget; 2016 Jan; 7(1):524-37. PubMed ID: 26594798
[TBL] [Abstract][Full Text] [Related]
12. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
[TBL] [Abstract][Full Text] [Related]
13. OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway.
Li H; Miao Q; Xu CW; Huang JH; Zhou YF; Wu MJ
J Korean Med Sci; 2016 Aug; 31(8):1215-23. PubMed ID: 27478331
[TBL] [Abstract][Full Text] [Related]
14. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
[TBL] [Abstract][Full Text] [Related]
15. Identifying target genes of the aryl hydrocarbon receptor nuclear translocator (Arnt) using DNA microarray analysis.
Wang F; Shi S; Zhang R; Hankinson O
Biol Chem; 2006 Sep; 387(9):1215-8. PubMed ID: 16972789
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis.
Liu Y; Xu L; Zeng Q; Wang J; Wang M; Xi D; Wang X; Yang D; Luo X; Ning Q
Liver Int; 2012 Nov; 32(10):1585-95. PubMed ID: 22925132
[TBL] [Abstract][Full Text] [Related]
17. Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia.
Choi SH; Chung AR; Kang W; Park JY; Lee MS; Hwang SW; Kim DY; Kim SU; Ahn SH; Kim S; Han KH
PLoS One; 2014; 9(7):e103304. PubMed ID: 25068796
[TBL] [Abstract][Full Text] [Related]
18. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ
Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580
[TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator expression in human and rat placentas and transcription activity in human trophoblast cultures.
Stejskalova L; Vecerova L; Peréz LM; Vrzal R; Dvorak Z; Nachtigal P; Pavek P
Toxicol Sci; 2011 Sep; 123(1):26-36. PubMed ID: 21666223
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor nuclear translocator in human liver is regulated by miR-24.
Oda Y; Nakajima M; Mohri T; Takamiya M; Aoki Y; Fukami T; Yokoi T
Toxicol Appl Pharmacol; 2012 May; 260(3):222-31. PubMed ID: 22387692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
